Cost Effectiveness [qnco]
Pravastatin [orch, phsu]
Secondary Prevention [topp]
Patients [podg]
Myocardial Infarction [dsyn]
Instability [fndg]
Angina [sosy]
Germany [geoa]
Analysis [lbpr]
Basis [ftcn]
Lipid [lipd]
Trial [resa]
Secondary Prevention [topp]
coronary [bpoc]
Lipid lowering drug [phsu]
Major [qlco]
Issue [fndg]
Health Policy [rnlw]
Formulation [resa]
Large [qnco]
Investment [mnob]
Drug Therapy [topp]
Recently [tmco]
COMPLETED [qlco]
Lipid [lipd]
Trial [resa]
Pravastatin [orch, phsu]
Secondary Prevention [topp]
Immediately [tmco]
Question [inpr]
Pravastatin [orch, phsu]
Cost Effectiveness [qnco]
Germany [geoa]
Conduct [inbe]
Cost Effectiveness Analysis [ocac]
Third-Party Payers [hcro]
Following [tmco]
Costs [qnco]
included [ftcn]
Analysis [lbpr]
Daily [tmco]
treatment [ftcn]
Cost [qnco]
Pravastatin [orch, phsu]
Non [ftcn]
Fatal [qlco]
Myocardial Infarction [dsyn]
coronary bypass [topp]
operations [ftcn]
Stroke [dsyn]
Life [idcn]
Gain [qnco]
Obtained [ftcn]
Apply [hlca]
Declining [qlco]
exponential [qlco]
Life Expectancy [grpa]
Calculation [acty]
treated [topp]
Patients [podg]
Reticular [spco]
Costs [qnco]
treating [topp]
Patients [podg]
i e [diap, inpr]
Drug Costs [qnco]
Minus [qlco]
Costs [qnco]
sequelae [patf]
interventions [hlca]
MIO [gngm]
Addition [ftcn]
Life [idcn]
Save [mcha]
treatment [ftcn]
Cost Effectiveness [qnco]
Pravastatin [orch, phsu]
treatment [ftcn]
discount [inpr]
P NOS [aapp, imft]
Result [ftcn]
Suggest [idcn]
Cost Effectiveness [qnco]
Pravastatin [orch, phsu]
Secondary Prevention [topp]
Well [qlco]
Threshold [qlco]
Accepted [qlco]
Medical [ftcn]
interventions [hlca]
MA [idcn]
considered [idcn]
Economically [ocdi]
Viable [qlco]
Approach [spco]
Secondary Prevention [topp]
coronary [bpoc]
